BIB ProShares Ultra Nasdaq Biotechnology
Issuer
ProShares
Inception
Apr 7, 2010
AUM
$103.3M
Expense ratio
1.17%
Yield
0.19%
Asset class
Equity
Holdings
274
Last price
$116.13
ProShares Trust - ProShares Ultra Nasdaq Biotechnology is an exchange traded fund launched and managed by ProShare Advisors LLC. It invests in public equity markets of the United States. It invests through derivatives in stocks of companies operating across health care, pharmaceuticals, biotechnology, drugs manufacturer, diagnostic development and life sciences sectors. It uses derivatives such as swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track 2x the daily performance of the Nasdaq Biotechnology Index, by using full replication technique. ProShares Trust - ProShares Ultra Nasdaq Biotechnology was formed on April 7, 2010 and is domiciled in the United States.
+53.9%
2025-11-14low 73.81 · high 126.222026-11-13
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| BIB | +8.7% | +8.7% | +45.7% | +56.3% | +39.9% | +6.9% |
| Equity average (4726 funds) | -1.9% | -4.6% | +3140.1% | +1994.4% | +12.3% | +2.6% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$663K net.
| Holding | Weight | Insiders bought | Insiders sold |
|---|---|---|---|
| KOD KODIAK SCIENCES INC | 0.28% | $181.3M | $2.7M |
| LYEL LYELL IMMUNOPHARMA INC | 0.02% | $50.0M | $216K |
| MDGL MADRIGAL PHARMACEUTICALS INC | 0.40% | $35.0M | $7.0M |
| RAPP RAPPORT THERAPEUTICS INC | 0.05% | $22.0M | $4.5M |
| SRRK SCHOLAR ROCK HOLDING CORP | 0.21% | $12.0M | $0 |
| ALMS ALUMIS INC | 0.03% | $10.7M | $1.0M |
| PRTA PROTHENA CORP PLC | 0.02% | $9.8M | $0 |
| INBX INHIBRX BIOSCIENCES INC | 0.05% | $6.3M | $279K |
| OBIO ORCHESTRA BIOMED HOLDINGS IN | 0.02% | $6.3M | $256K |
| KURA KURA ONCOLOGY INC | 0.03% | $2.4M | $1.7M |
| XENE XENON PHARMACEUTICALS INC | 0.16% | $1.7M | $426K |
| ABCL ABCELLERA BIOLOGICS INC | 0.15% | $1.5M | $0 |
| RGNX REGENXBIO INC | 0.02% | $949K | $0 |
| ALNY ALNYLAM PHARMACEUTICALS INC | 0.85% | $543K | $399K |
| LRMR LARIMAR THERAPEUTICS INC | 0.01% | $382K | $0 |
Holdings · as of Nov 13, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | BIB Net Other Assets (Liabilities) | 20.46% |
| 2 | IQMM PROSHARES GENIUS MNY MKT ETF | 16.47% |
| 3 | GILD GILEAD SCIENCES INC | 5.70% |
| 4 | AMGN AMGEN INC | 5.39% |
| 5 | VRTX VERTEX PHARMACEUTICALS INC | 4.95% |
| 6 | REGN REGENERON PHARMACEUTICALS | 3.91% |
| 7 | MRNA MODERNA INC | 3.75% |
| 8 | RVMD REVOLUTION MEDICINES INC | 1.54% |
| 9 | BIIB BIOGEN INC | 1.50% |
| 10 | ILMN ILLUMINA INC | 1.29% |
| 11 | RPRX ROYALTY PHARMA PLC- CL A | 1.24% |
| 12 | ROIV ROIVANT SCIENCES LTD | 1.17% |
| 13 | ARGX ARGENX SE - ADR | 1.09% |
| 14 | INSM INSMED INC | 1.05% |
| 15 | UTHR UNITED THERAPEUTICS CORP | 1.03% |
| 16 | INCY INCYTE CORP | 1.00% |
| 17 | VTRS VIATRIS INC | 0.96% |
| 18 | ALNY ALNYLAM PHARMACEUTICALS INC | 0.85% |
| 19 | GH GUARDANT HEALTH INC | 0.84% |
| 20 | MEDP MEDPACE HOLDINGS INC | 0.75% |
| 21 | EXEL EXELIXIS INC | 0.70% |
| 22 | NBIX NEUROCRINE BIOSCIENCES INC | 0.70% |
| 23 | ASND ASCENDIS PHARMA A/S | 0.67% |
| 24 | BBIO BRIDGEBIO PHARMA INC | 0.64% |
| 25 | JAZZ JAZZ PHARMACEUTICALS PLC | 0.63% |
| 26 | ONC BEONE MEDICINES LTD-ADR | 0.61% |
| 27 | TEM TEMPUS AI INC-CL A | 0.54% |
| 28 | SMMT SUMMIT THERAPEUTICS INC | 0.49% |
| 29 | HALO HALOZYME THERAPEUTICS INC | 0.46% |
| 30 | BMRN BIOMARIN PHARMACEUTICAL INC | 0.45% |
| 31 | KYMR KYMERA THERAPEUTICS INC | 0.43% |
| 32 | SNY SANOFI-ADR | 0.42% |
| 33 | BNTX BIONTECH SE-ADR | 0.40% |
| 34 | MDGL MADRIGAL PHARMACEUTICALS INC | 0.40% |
| 35 | PCVX VAXCYTE INC | 0.39% |
| 36 | SYRE SPYRE THERAPEUTICS INC | 0.37% |
| 37 | PRAX PRAXIS PRECISION MEDICINES I | 0.37% |
| 38 | KRYS KRYSTAL BIOTECH INC | 0.37% |
| 39 | PTGX PROTAGONIST THERAPEUTICS INC | 0.35% |
| 40 | ALKS ALKERMES PLC | 0.32% |
| 41 | CYTK CYTOKINETICS INC | 0.32% |
| 42 | TWST TWIST BIOSCIENCE CORP | 0.31% |
| 43 | AXSM AXSOME THERAPEUTICS INC | 0.31% |
| 44 | RYTM RHYTHM PHARMACEUTICALS INC | 0.31% |
| 45 | AMRX AMNEAL PHARMACEUTICALS INC | 0.31% |
| 46 | IMVT IMMUNOVANT INC | 0.29% |
| 47 | TXG 10X GENOMICS INC-CLASS A | 0.29% |
| 48 | ORKA ORUKA THERAPEUTICS INC | 0.28% |
| 49 | KOD KODIAK SCIENCES INC | 0.28% |
| 50 | CAI CARIS LIFE SCIENCES INC | 0.28% |
| 51 | ARWR ARROWHEAD PHARMACEUTICALS IN | 0.27% |
| 52 | IBRX IMMUNITYBIO INC | 0.26% |
| 53 | LGND LIGAND PHARMACEUTICALS | 0.26% |
| 54 | CGON CG ONCOLOGY INC | 0.25% |
| 55 | MIRM MIRUM PHARMACEUTICALS INC | 0.25% |
| 56 | SUPN SUPERNUS INC | 0.25% |
| 57 | ERAS ERASCA INC | 0.22% |
| 58 | GRAL GRAIL INC | 0.22% |
| 59 | PTCT PTC THERAPEUTICS INC | 0.21% |
| 60 | SRRK SCHOLAR ROCK HOLDING CORP | 0.21% |
| 61 | ABVX ABIVAX SA-ADR | 0.21% |
| 62 | COGT COGENT BIOSCIENCES INC | 0.21% |
| 63 | GMAB GENMAB A/S -SP ADR | 0.20% |
| 64 | EWTX EDGEWISE THERAPEUTICS INC | 0.20% |
| 65 | TVTX TRAVERE THERAPEUTICS INC | 0.20% |
| 66 | ADPT ADAPTIVE BIOTECHNOLOGIES | 0.19% |
| 67 | KNSA KINIKSA PHARMACEUTICALS INTE | 0.19% |
| 68 | IONS IONIS PHARMACEUTICALS INC | 0.18% |
| 69 | DFTX DEFINIUM THERAPEUTICS INC | 0.18% |
| 70 | TNGX TANGO THERAPEUTICS INC | 0.17% |
| 71 | CRSP CRISPR THERAPEUTICS AG | 0.17% |
| 72 | XENE XENON PHARMACEUTICALS INC | 0.16% |
| 73 | RLAY RELAY THERAPEUTICS INC | 0.16% |
| 74 | ABCL ABCELLERA BIOLOGICS INC | 0.15% |
| 75 | AMLX AMYLYX PHARMACEUTICALS INC | 0.15% |
| 76 | ELVN ENLIVEN THERAPEUTICS INC | 0.14% |
| 77 | TARS TARSUS PHARMACEUTICALS INC | 0.14% |
| 78 | ARQT ARCUTIS BIOTHERAPEUTICS INC | 0.14% |
| 79 | IOVA IOVANCE BIOTHERAPEUTICS INC | 0.14% |
| 80 | IRON DISC MEDICINE INC | 0.13% |
| 81 | DYN DYNE THERAPEUTICS INC | 0.13% |
| 82 | ACAD ACADIA PHARMACEUTICALS INC | 0.13% |
| 83 | IDYA IDEAYA BIOSCIENCES INC | 0.12% |
| 84 | XERS XERIS BIOPHARMA HOLDINGS INC | 0.12% |
| 85 | DNLI DENALI THERAPEUTICS INC | 0.12% |
| 86 | ADMA ADMA BIOLOGICS INC | 0.12% |
| 87 | VCEL VERICEL CORP | 0.12% |
| 88 | XNCR XENCOR INC | 0.12% |
| 89 | MBX MBX BIOSCIENCES INC | 0.11% |
| 90 | BEAM BEAM THERAPEUTICS INC | 0.10% |
| 91 | PHVS PHARVARIS NV | 0.10% |
| 92 | AUPH AURINIA PHARMACEUTICALS INC | 0.09% |
| 93 | VERA VERA THERAPEUTICS INC | 0.09% |
| 94 | REPL REPLIMUNE GROUP INC | 0.08% |
| 95 | VIR VIR BIOTECHNOLOGY INC | 0.08% |
| 96 | MAZE MAZE THERAPEUTICS INC | 0.08% |
| 97 | VCYT VERACYTE INC | 0.08% |
| 98 | HRMY HARMONY BIOSCIENCES HOLDINGS | 0.08% |
| 99 | BCRX BIOCRYST PHARMACEUTICALS INC | 0.08% |
| 100 | SEPN SEPTERNA INC | 0.08% |
| 101 | TRVI TREVI THERAPEUTICS INC | 0.08% |
| 102 | FTRE FORTREA HOLDINGS INC | 0.08% |
| 103 | AGIO AGIOS PHARMACEUTICALS INC | 0.08% |
| 104 | ZYME ZYMEWORKS INC | 0.08% |
| 105 | ZBIO ZENAS BIOPHARMA INC | 0.07% |
| 106 | RXRX RECURSION PHARMACEUTICALS-A | 0.07% |
| 107 | ETON ETON PHARMACEUTICALS INC | 0.07% |
| 108 | TRAX FIRST TRACKS BIOTHERAPEUTICS | 0.07% |
| 109 | QURE UNIQURE NV | 0.07% |
| 110 | LEGN LEGEND BIOTECH CORP-ADR | 0.07% |
| 111 | PSNL PERSONALIS INC | 0.07% |
| 112 | SRPT SAREPTA THERAPEUTICS INC | 0.07% |
| 113 | STOK STOKE THERAPEUTICS INC | 0.07% |
| 114 | PGEN PRECIGEN INC | 0.07% |
| 115 | ANIP ANI PHARMACEUTICALS INC | 0.07% |
| 116 | GPCR STRUCTURE THERAPEUTICS INC | 0.07% |
| 117 | NRIX NURIX THERAPEUTICS INC | 0.07% |
| 118 | RARE ULTRAGENYX PHARMACEUTICAL IN | 0.07% |
| 119 | ALVO ALVOTECH SA | 0.06% |
| 120 | ABSI ABSCI CORP | 0.06% |
| 121 | NTLA INTELLIA THERAPEUTICS INC | 0.06% |
| 122 | PCRX PACIRA BIOSCIENCES INC | 0.06% |
| 123 | NVAX NOVAVAX INC | 0.06% |
| 124 | ANAB ANAPTYSBIO INC | 0.06% |
| 125 | IMCR IMMUNOCORE HOLDINGS PLC-ADR | 0.06% |
| 126 | OCUL OCULAR THERAPEUTIX INC | 0.06% |
| 127 | TSHA TAYSHA GENE THERAPIES INC | 0.06% |
| 128 | INVA INNOVIVA INC | 0.06% |
| 129 | MLYS MINERALYS THERAPEUTICS INC | 0.06% |
| 130 | NVCR NOVOCURE LTD | 0.06% |
| 131 | MNKD MANNKIND CORP | 0.05% |
| 132 | OMER OMEROS CORP | 0.05% |
| 133 | URGN UROGEN PHARMA LTD | 0.05% |
| 134 | INBX INHIBRX BIOSCIENCES INC | 0.05% |
| 135 | GHRS GH RESEARCH PLC | 0.05% |
| 136 | RAPP RAPPORT THERAPEUTICS INC | 0.05% |
| 137 | AMPH AMPHASTAR PHARMACEUTICALS IN | 0.05% |
| 138 | CMPS COMPASS PATHWAYS PLC | 0.05% |
| 139 | TYRA TYRA BIOSCIENCES INC | 0.05% |
| 140 | ZLAB ZAI LAB LTD-ADR | 0.05% |
| 141 | MRVI MARAVAI LIFESCIENCES HLDGS-A | 0.05% |
| 142 | VOR VOR BIOPHARMA INC | 0.05% |
| 143 | HROW HARROW INC | 0.04% |
| 144 | CSTL CASTLE BIOSCIENCES INC | 0.04% |
| 145 | SVRA SAVARA INC | 0.04% |
| 146 | SLN SILENCE THERAPEUTICS PLC-ADR | 0.04% |
| 147 | CRVS CORVUS PHARMACEUTICALS INC | 0.04% |
| 148 | ORIC ORIC PHARMACEUTICALS INC | 0.04% |
| 149 | RIGL RIGEL PHARMACEUTICALS INC | 0.03% |
| 150 | SNDX SYNDAX PHARMACEUTICALS INC | 0.03% |
| 151 | MGTX MEIRAGTX HOLDINGS PLC | 0.03% |
| 152 | COLL COLLEGIUM PHARMACEUTICAL INC | 0.03% |
| 153 | IRWD IRONWOOD PHARMACEUTICALS INC | 0.03% |
| 154 | ABUS ARBUTUS BIOPHARMA CORP | 0.03% |
| 155 | GLUE MONTE ROSA THERAPEUTICS INC | 0.03% |
| 156 | ALMS ALUMIS INC | 0.03% |
| 157 | ARDX ARDELYX INC | 0.03% |
| 158 | ANNX ANNEXON INC | 0.03% |
| 159 | SLDB SOLID BIOSCIENCES INC | 0.03% |
| 160 | PAHC PHIBRO ANIMAL HEALTH CORP-A | 0.03% |
| 161 | AURA AURA BIOSCIENCES INC | 0.03% |
| 162 | OABI OMNIAB INC | 0.03% |
| 163 | PRME PRIME MEDICINE INC | 0.03% |
| 164 | JANX JANUX THERAPEUTICS INC | 0.03% |
| 165 | MESO MESOBLAST LTD- SPON ADR | 0.03% |
| 166 | SGMT SAGIMET BIOSCIENCES INC-A | 0.03% |
| 167 | FDMT 4D MOLECULAR THERAPEUTICS IN | 0.03% |
| 168 | BCAX BICARA THERAPEUTICS INC | 0.03% |
| 169 | ZVRA ZEVRA THERAPEUTICS INC | 0.03% |
| 170 | DSGN DESIGN THERAPEUTICS INC | 0.03% |
| 171 | KURA KURA ONCOLOGY INC | 0.03% |
| 172 | OLMA OLEMA PHARMACEUTICALS INC | 0.03% |
| 173 | CGEM CULLINAN THERAPEUTICS INC | 0.03% |
| 174 | AVBP ARRIVENT BIOPHARMA INC | 0.03% |
| 175 | CADL CANDEL THERAPEUTICS INC | 0.03% |
| 176 | GERN GERON CORP | 0.03% |
| 177 | WVE WAVE LIFE SCIENCES INC | 0.03% |
| 178 | PACB PACIFIC BIOSCIENCES OF CALIF | 0.02% |
| 179 | SANA SANA BIOTECHNOLOGY INC | 0.02% |
| 180 | ACRS ACLARIS THERAPEUTICS INC | 0.02% |
| 181 | RGNX REGENXBIO INC | 0.02% |
| 182 | LKFT LAKEFRONT BIOTHERAPEUTIC-ADR | 0.02% |
| 183 | PHAT PHATHOM PHARMACEUTICALS INC | 0.02% |
| 184 | NGNE NEUROGENE INC | 0.02% |
| 185 | EOLS EVOLUS INC | 0.02% |
| 186 | KMDA KAMADA LTD | 0.02% |
| 187 | ARVN ARVINAS INC | 0.02% |
| 188 | AQST AQUESTIVE THERAPEUTICS INC | 0.02% |
| 189 | TKNO ALPHA TEKNOVA INC | 0.02% |
| 190 | CTMX CYTOMX THERAPEUTICS INC | 0.02% |
| 191 | PRTA PROTHENA CORP PLC | 0.02% |
| 192 | PBYI PUMA BIOTECHNOLOGY INC | 0.02% |
| 193 | TECX TECTONIC THERAPEUTIC INC | 0.02% |
| 194 | LYEL LYELL IMMUNOPHARMA INC | 0.02% |
| 195 | SPRY ARS PHARMACEUTICALS INC | 0.02% |
| 196 | CRMD CORMEDIX INC | 0.02% |
| 197 | OBIO ORCHESTRA BIOMED HOLDINGS IN | 0.02% |
| 198 | PEPG PEPGEN INC | 0.01% |
| 199 | CCCC C4 THERAPEUTICS INC | 0.01% |
| 200 | AVIR ATEA PHARMACEUTICALS INC | 0.01% |
| 201 | EDIT EDITAS MEDICINE INC | 0.01% |
| 202 | ENTA ENANTA PHARMACEUTICALS INC | 0.01% |
| 203 | CTNM CONTINEUM THERAPEUTICS INC-A | 0.01% |
| 204 | ALT ALTIMMUNE INC | 0.01% |
| 205 | KYTX KYVERNA THERAPEUTICS INC | 0.01% |
| 206 | ALLO ALLOGENE THERAPEUTICS INC | 0.01% |
| 207 | FULC FULCRUM THERAPEUTICS INC | 0.01% |
| 208 | LRMR LARIMAR THERAPEUTICS INC | 0.01% |
| 209 | RCKT ROCKET PHARMACEUTICALS INC | 0.01% |
| 210 | BIOA BIOAGE LABS INC | 0.01% |
| 211 | QSI QUANTUM-SI INC | 0.01% |
| 212 | LFCR LIFECORE BIOMEDICAL INC | 0.01% |
| 213 | ARCT ARCTURUS THERAPEUTICS HOLDIN | 0.01% |
| 214 | VNDA VANDA PHARMACEUTICALS INC | 0.01% |
| 215 | LXEO LEXEO THERAPEUTICS INC | 0.01% |
| 216 | AUTL AUTOLUS THERAPEUTICS PLC | 0.01% |
| 217 | IMRX IMMUNEERING CORP - CLASS A | 0.01% |
| 218 | CABA CABALETTA BIO INC | 0.01% |
| 219 | ACIU AC IMMUNE SA | 0.01% |
| 220 | SIGA SIGA TECHNOLOGIES INC | 0.01% |
| 221 | TRDA ENTRADA THERAPEUTICS INC | 0.01% |
| 222 | KROS KEROS THERAPEUTICS INC | 0.01% |
| 223 | IVVD INVIVYD INC | 0.01% |
| 224 | HUMA HUMACYTE INC | 0.01% |
| 225 | BCYC BICYCLE THERAPEUTICS PLC-ADR | 0.01% |
| 226 | UPB UPSTREAM BIO INC | 0.01% |
| 227 | SION SIONNA THERAPEUTICS INC | 0.01% |
| 228 | PYXS PYXIS ONCOLOGY INC | 0.01% |
| 229 | LENZ LENZ THERAPEUTICS INC | 0.01% |
| 230 | MENS JYONG BIOTECH LTD | 0.01% |
| 231 | FHTX FOGHORN THERAPEUTICS INC | 0.00% |
| 232 | CDXS CODEXIS INC | 0.00% |
| 233 | VYGR VOYAGER THERAPEUTICS INC | 0.00% |
| 234 | NBP NOVABRIDGE BIOSCIENCES | 0.00% |
| 235 | AVXL ANAVEX LIFE SCIENCES CORP | 0.00% |
| 236 | BDTX BLACK DIAMOND THERAPEUTICS I | 0.00% |
| 237 | CHRS COHERUS ONCOLOGY INC | 0.00% |
| 238 | NMRA NEUMORA THERAPEUTICS INC | 0.00% |
| 239 | TNYA TENAYA THERAPEUTICS INC | 0.00% |
| 240 | GOSS GOSSAMER BIO INC | 0.00% |
| 241 | RANI RANI THERAPEUTICS HOLDINGS-A | 0.00% |
| 242 | CRBU CARIBOU BIOSCIENCES INC | 0.00% |
| 243 | AARD AARDVARK THERAPEUTICS INC | 0.00% |
| 244 | EYPT EYEPOINT INC | 0.00% |
| 245 | THRD THIRD HARMONIC BIO INC | 0.00% |
Sector breakdown
Healthcare62.8%
Cash & Others21.5%
Government15.6%
Country breakdown
United States95.0%
United Kingdom2.1%
France1.0%
Canada0.5%
Netherlands0.4%
Denmark0.3%
Switzerland0.3%
Ireland0.1%
China0.1%
Spain0.1%
Australia0.1%
Israel0.0%
Distributions
| Date | Per unit |
|---|---|
| Sep 23, 2026 | $0.0826 |
| Mar 25, 2026 | $0.0071 |
| Dec 24, 2025 | $0.1346 |
| Sep 24, 2025 | $0.1805 |
| Jun 25, 2025 | $0.1706 |
| Mar 26, 2025 | $0.1309 |
| Dec 23, 2024 | $0.3964 |
| Sep 25, 2024 | $0.1529 |
| Jun 26, 2024 | $0.2648 |
| Mar 20, 2024 | $0.0403 |
| Dec 20, 2023 | $0.0384 |
| Dec 22, 2022 | $0.0199 |
| Sep 21, 2010 | $0.0110 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in BIB in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 14, 2026. This is historical data, not investment advice. Report a data error